coronary heart disease
Conditions
Interventions
Control group:Placebo
Sponsors
The department of geriatric, Wuhan Union Hospital,Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: The selected cases shall meet both 1 and 2 and one of 3 and 4 inclusion criteria: 1. Stable coronary heart disease patients with typical angina after routine drug treatment; 2. Evidence of myocardial ischemia: ECG indicates positive myocardial ischemia or exercise load test; 3. No obvious lumen stenosis was found by coronary angiography or CTA: left main coronary artery stenosis 2mm; 4. Patients who received PCI or CABG to relieve epicardial vascular obstruction.
Exclusion criteria
Exclusion criteria: 1. Other cardiovascular diseases, such as congenital heart disease, rheumatic heart disease, severe arrhythmia, severe heart failure, etc.; 2. Patients with serious liver and kidney disease, gastrointestinal hemorrhage and serious infection; 3. Combined with tumor diseases or other major diseases that seriously affect survival; 4. Neuropsychiatric diseases or cognitive dysfunction; 5. Participants in other clinical trials within the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom of chest pain;vascular endothelial function;coronary flow reserve; | — |
Secondary
| Measure | Time frame |
|---|---|
| Inflammatory factors; | — |
Countries
China
Contacts
Public ContactQi Benling
The department of geriatric, Wuhan Union Hospital,Huazhong University of Science and Technology
Outcome results
None listed